See analyst estimates and all valuation multiples for Pharma Diagnostics & Analytics
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $9.8B | 8.0x | 22.7x | |
| $9.3B | n/a | n/a | |
| $2.5B | 10.7x | -60.2x | |
| $1.4B | 4.9x | -10.9x | |
| $1.1B | n/a | n/a | |
| $394M | 216.4x | -12.2x | |
| $273M | n/a | n/a | |
| $172M | 3.3x | 19.2x | |
| $149M | 48.9x | -7.6x | |
| $123M | 7.1x | 9.3x | |
| $75.7M | 6.6x | -4.2x | |
| $73.7M | n/a | -1.1x | |
| $49.4M | 2.8x | 15.1x | |
| $31.7M | 39.4x | -11.7x | |
| $29.2M | 11.9x | -6.0x | |
| $29.0M | 19.2x | -18.7x | |
| $18.1M | 0.7x | n/a | |
| $4.7M | n/a | n/a |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharma Diagnostics & Analytics